Abstract
Chronic obstructive pulmonary disease (COPD) is characterised by both an accelerated decline in lung function and periods of acute deterioration in symptoms termed exacerbations. The aim of this study was to investigate whether these are related. Over 4 years, peak expiratory flow (PEF) and symptoms were measured at home daily by 109 patients with COPD (81 men; median (IQR) age 68.1 (63-74) years; arterial oxygen tension (PaO(2)) 9.00 (8.3-9.5) kPa, forced expiratory volume in 1 second (FEV(1)) 1.00 (0.7-1.3) l, forced vital capacity (FVC) 2.51 (1.9-3.0) l); of these, 32 (29 men) recorded daily FEV(1). Exacerbations were identified from symptoms and the effect of frequent or infrequent exacerbations (> or < 2.92 per year) on lung function decline was examined using cross sectional, random effects models. The 109 patients experienced 757 exacerbations. Patients with frequent exacerbations had a significantly faster decline in FEV(1) and peak expiratory flow (PEF) of -40.1 ml/year (n=16) and -2.9 l/min/year (n=46) than infrequent exacerbators in whom FEV(1) changed by -32.1 ml/year (n=16) and PEF by -0.7 l/min/year (n=63). Frequent exacerbators also had a greater decline in FEV(1) if allowance was made for smoking status. Patients with frequent exacerbations were more often admitted to hospital with longer length of stay. Frequent exacerbations were a consistent feature within a patient, with their number positively correlated (between years 1 and 2, 2 and 3, 3 and 4). These results suggest that the frequency of exacerbations contributes to long term decline in lung function of patients with moderate to severe COPD.
MeSH Terms
Administration, Inhalation
Administration, Oral
Aged
Female
Forced Expiratory Volume/physiology
Humans
Lung/physiopathology
Male
Middle Aged
Peak Expiratory Flow Rate/physiology
Prednisolone/therapeutic use
Prognosis
Prospective Studies
Pulmonary Disease, Chronic Obstructive/drug therapy,physiopathology
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Donaldson G C
Academic Unit of Respiratory Medicine, St Bartholomew's and Royal London School of Medicine and Dentistry, UK.
Seemungal T A R
Bhowmik A
Wedzicha J A
References (22)
22 references, click to expand
-
Airway inflammation and bronchial microbial patterns in patients with stable chronic obstructive pulmonary disease.
Eur Respir J. 1999 Nov;14(5):1015-22
PMID: 10596683
-
Relationship between bacterial flora in sputum and functional impairment in patients with acute exacerbations of COPD. Study Group of Bacterial Infection in COPD.
Chest. 1999 Jul;116(1):40-6
PMID: 10424501
-
Relation of sputum inflammatory markers to symptoms and lung function changes in COPD exacerbations.
Thorax. 2000 Feb;55(2):114-20
PMID: 10639527
-
Acute exacerbation of COPD: factors associated with poor treatment outcome.
Chest. 2000 Mar;117(3):662-71
PMID: 10712989
-
Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial.
BMJ. 2000 May 13;320(7245):1297-303
PMID: 10807619
-
Time course and recovery of exacerbations in patients with chronic obstructive pulmonary disease.
Am J Respir Crit Care Med. 2000 May;161(5):1608-13
PMID: 10806163
-
Association between airway bacterial load and markers of airway inflammation in patients with stable chronic bronchitis.
Am J Med. 2000 Sep;109(4):288-95
PMID: 10996579
-
Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary.
Am J Respir Crit Care Med. 2001 Apr;163(5):1256-76
PMID: 11316667
-
Lower respiratory illnesses promote FEV(1) decline in current smokers but not ex-smokers with mild chronic obstructive pulmonary disease: results from the lung health study.
Am J Respir Crit Care Med. 2001 Aug 1;164(3):358-64
PMID: 11500333
-
Risk factors for hospitalization for a chronic obstructive pulmonary disease exacerbation. EFRAM study.
Am J Respir Crit Care Med. 2001 Sep 15;164(6):1002-7
PMID: 11587986
-
Respiratory viruses, symptoms, and inflammatory markers in acute exacerbations and stable chronic obstructive pulmonary disease.
Am J Respir Crit Care Med. 2001 Nov 1;164(9):1618-23
PMID: 11719299
-
Relationship between bacterial colonisation and the frequency, character, and severity of COPD exacerbations.
Thorax. 2002 Sep;57(9):759-64
PMID: 12200518
-
Variables associated with changes in spirometry in patients with obstructive lung diseases.
Am J Med. 1979 Jul;67(1):44-50
PMID: 313706
-
Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease.
Ann Intern Med. 1987 Feb;106(2):196-204
PMID: 3492164
-
Arterialised earlobe blood gas analysis: an underused technique.
Thorax. 1994 Apr;49(4):364-6
PMID: 8202909
-
Association of chronic mucus hypersecretion with FEV1 decline and chronic obstructive pulmonary disease morbidity. Copenhagen City Heart Study Group.
Am J Respir Crit Care Med. 1996 May;153(5):1530-5
PMID: 8630597
-
Effects of long-term treatment with corticosteroids in COPD.
Chest. 1996 May;109(5):1156-62
PMID: 8625660
-
Changing smoking patterns and mortality from chronic obstructive pulmonary disease.
Prev Med. 1997 Jul-Aug;26(4):418-21
PMID: 9245659
-
Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease.
Am J Respir Crit Care Med. 1998 May;157(5 Pt 1):1418-22
PMID: 9603117
-
Severity of airflow limitation is associated with severity of airway inflammation in smokers.
Am J Respir Crit Care Med. 1998 Oct;158(4):1277-85
PMID: 9769292
-
Risk factors for lower airway bacterial colonization in chronic bronchitis.
Eur Respir J. 1999 Feb;13(2):338-42
PMID: 10065678
-
Predisposing factors to bacterial colonization in chronic obstructive pulmonary disease.
Eur Respir J. 1999 Feb;13(2):343-8
PMID: 10065679